{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:05:34Z","timestamp":1788246334733,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.intimp.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,12]],"date-time":"2014-07-12T12:00:18Z","timestamp":1405166418000},"page":"266-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL\/lpr mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Xueqin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.intimp.2014.07.001_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","article-title":"Antimalarial combinations","volume":"364","author":"Kremsner","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2014.07.001_bb0015","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.01066-05","article-title":"The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release","volume":"50","author":"Wang","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.intimp.2014.07.001_bb0020","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.4049\/jimmunol.1200919","article-title":"Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway","volume":"189","author":"Zhao","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2014.07.001_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2011.06.008","article-title":"Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo","volume":"271","author":"Noori","year":"2011","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2014.07.001_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.intimp.2009.11.002","article-title":"Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses","volume":"10","author":"Noori","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2014.07.001_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crispin","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.intimp.2014.07.001_bb0045","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.intimp.2014.07.001_bb0050","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.20508","article-title":"Interferon-alpha-inducible proteins are novel autoantigens in murine lupus","volume":"50","author":"Hueber","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2014.07.001_bb0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2014.07.001_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (\u03b1\/\u03b2) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2014.07.001_bb0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/BOR.0b013e3283562c3e","article-title":"Type I IFN system in the development and manifestations of SLE","volume":"24","author":"Elkon","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2014.07.001_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"R\u00f6nnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.intimp.2014.07.001_bb0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaut.2010.07.007","article-title":"Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes","volume":"35","author":"Lee","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.intimp.2014.07.001_bb0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0006-291X(03)01049-0","article-title":"Essential role of IRF-3 in lipopolysaccharide-induced interferon-\u03b2 gene expression and endotoxin shock","volume":"306","author":"Sakaguchi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2014.07.001_bb0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","article-title":"Infections and SLE","volume":"38","author":"Zandman-Goddard","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2014.07.001_bb0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nm1590","article-title":"TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity","volume":"13","author":"Baccala","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.intimp.2014.07.001_bb0095","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2014.07.001_bb0100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/intimm\/dxf089","article-title":"Differential involvement of IFN-\u03b2 in Toll-like receptor-stimulated dendritic cell activation","volume":"14","author":"Hoshino","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","article-title":"IRF3 mediates a TLR3\/TLR4-specific antiviral gene program","volume":"17","author":"Doyle","year":"2002","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2014.07.001_bb0110","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.4049\/jimmunol.0803219","article-title":"Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus","volume":"183","author":"Lartigue","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2014.07.001_bb0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pharmthera.2013.03.003","article-title":"Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases","volume":"138","author":"Li","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.intimp.2014.07.001_bb0120","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.M109.031476","article-title":"Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways","volume":"285","author":"Suzuki","year":"2010","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.intimp.2014.07.001_bb0125","first-page":"676","article-title":"Effect of dihydroarteannuin on auto-antibody production TNF-alpha secretion and pathologic change of lupus nephritis in BXSB mice","volume":"23","author":"Dong","year":"2003","journal-title":"Chin J Integr Tradit West Med"},{"key":"10.1016\/j.intimp.2014.07.001_bb0130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation","volume":"6","author":"Li","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2014.07.001_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/etm.2013.1382","article-title":"Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells","volume":"7","author":"Nagaya","year":"2014","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.intimp.2014.07.001_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15287394.2012.722521","article-title":"Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of mice","volume":"76","author":"Lauer","year":"2013","journal-title":"J Toxicol Environ Health A"},{"issue":"42","key":"10.1016\/j.intimp.2014.07.001_bb0145","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.3748\/wjg.v13.i42.5612","article-title":"Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis","volume":"13","author":"Zhao","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.intimp.2014.07.001_bb0150","first-page":"838","article-title":"Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation","volume":"37","author":"Veerasubramanian","year":"2006","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.intimp.2014.07.001_bb0155","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.emboj.7600991","article-title":"Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity","volume":"25","author":"Husebye","year":"2006","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.intimp.2014.07.001_bb0160","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.intimp.2014.07.001_bb0165","doi-asserted-by":"crossref","first-page":"e3509","DOI":"10.1371\/journal.pone.0003509","article-title":"Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation","volume":"3","author":"Quintana","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2014.07.001_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.intimp.2007.10.024","article-title":"Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation","volume":"8","author":"Li","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"R\u00f6nnblom","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2014.07.001_bb0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/187153006779025702","article-title":"Type I interferon as a target of treatment in SLE","volume":"6","author":"Lee","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"7","key":"10.1016\/j.intimp.2014.07.001_bb0185","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","article-title":"A novel type I IFN-producing cell subset in murine lupus","volume":"180","author":"Lee","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2013.00306","article-title":"IFN\u03b1 inducible models of murine SLE","volume":"4","author":"Liu","year":"2013","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2014.07.001_bb0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.coi.2012.07.008","article-title":"The genetics of type I interferon in systemic lupus erythematosus","volume":"24","author":"Bronson","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0200","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/jir.2004.24.717","article-title":"An essential role for IFN-\u03b1 in the overexpression of Fas ligand on MRL\/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential","volume":"24","author":"Hadj-Slimane","year":"2004","journal-title":"J Interferon Cytokine Res"},{"issue":"10","key":"10.1016\/j.intimp.2014.07.001_bb0205","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jocn.2006.07.011","article-title":"Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient","volume":"14","author":"Gono","year":"2007","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.intimp.2014.07.001_bb0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0961203308093550","article-title":"Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis","volume":"18","author":"Bonaci-Nikolic","year":"2009","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.intimp.2014.07.001_bb0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1472-8206.2011.00929.x","article-title":"Systemic lupus erythematosus induced by interferon \u03b21 therapy in a patient with multiple sclerosis","volume":"26","author":"Bahri","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0220","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.173.3.2134","article-title":"Type I IFN protects against murine lupus","volume":"173","author":"Hron","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0225","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.4049\/jimmunol.1201477","article-title":"Anti-IFN-\u03b1\/\u03b2 receptor antibody treatment ameliorates disease in lupus-predisposed mice","volume":"189","author":"Baccala","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2014.07.001_bb0230","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.30392","article-title":"Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses","volume":"63","author":"Hou","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2014.07.001_bb0235","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2006-06-027862","article-title":"Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells","volume":"109","author":"Aksoy","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2014.07.001_bb0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.trsl.2011.01.006","article-title":"Interferon regulatory factors in human lupus pathogenesis","volume":"157","author":"Salloum","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.intimp.2014.07.001_bb0245","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.4049\/jimmunol.181.10.6797","article-title":"IFN-\u03b2 production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-\u03b2","volume":"181","author":"Wang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2014.07.001_bb0250","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.1102985","article-title":"IFN-\u03b2 expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling","volume":"189","author":"Tamassia","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2014.07.001_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-9255-10-23","article-title":"Hyaluronan fragments induce IFN\u03b2 via a novel TLR4\u2013TRIF\u2013TBK1\u2013IRF3-dependent pathway","volume":"10","author":"Black","year":"2013","journal-title":"J Inflamm (Lond)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T02:39:16Z","timestamp":1598063956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1567576914002562"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.07.001","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL\/lpr mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}